secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2023-10-24T23:59:59+00:00
Accession:  0001193125-23-261204
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Healthcare Q3 revenue $16.21B, EPS $3.91; FY 2023 guidance revised; dividend $0.60
--------------------------------------------------------------------------------

- Revenue $16.213B (+8.3% YoY); net income $1.079B ($3.91 diluted EPS, flat vs $3.91 prior year).
- Adjusted EBITDA $2.88B, down from $2.902B; same-facility admissions +3.4%, equivalent admissions +4.1%.
- FY 2023 guidance revised: revenue $63.5-$64.5B, adjusted EBITDA $12.3-$12.6B, EPS $17.80-$18.50.
- Board declared $0.60/share dividend payable Dec 28 to holders of record Dec 14; Q3 buyback $1.14B, $1.685B remaining.
- CEO cited solid demand but Valesco physician staffing JV performed below expectations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312523261204/0001193125-23-261204-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312523261204/d551352d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-261204

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer